1. Bergerheim, U. S., Kunimi, K., Collins, V. P. & Ekman, P. (1991). Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chroms Cancer 3: 215–220.
2. Brendler, C. B., Isaacs, J. T., Follansbee, A. L. & Walsh, P. C. (1984). The use of multiple variables to predict response to endocrine therapy in carcinoma of the prostate: a preliminary report. J Urol 131: 694–700.
3. Canzian, F., Salovaara, R., Hemminki, A., Kristo, P., Chadwick, R. B., Aaltonen, L. A. & de la Chapelle, A. (1996). Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 56: 3331–3337.
4. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I. & Isaacs, W. B. (1990). Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87: 8751–8755.
5. Cher, M. L., Bova, G. S., Moore, D. H., Small, E. J., Carroll, P. R., Pin, S. S., Epstein, J. I., Isaacs, W. B. & Jensen, R. H. (1996). Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56: 3091–3102.